Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.

Abstract

Meningiomas are the most common primary intracranial tumors. The majority of meningiomas are benign, but they can present different grades of dedifferentiation from grade I to grade III (anaplastic/malignant) that are associated with different outcomes. Radiological surveillance is a valid option for low-grade asymptomatic meningiomas. In other cases, the treatment is usually surgical, aimed at achieving a complete resection. The use of adjuvant radiotherapy is the gold standard for grade III, is debated for grade II and is not generally indicated for radically resected grade I meningiomas. The use of systemic treatments is not standardized. Here we report a review of the literature on the clinical, radiological and molecular characteristics of meningiomas, available treatment strategies and ongoing clinical trials.

• Authors: Ilaria Maggio, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Lidia Gatto, Raffaele Lodi, Alba A Brandes
• Journal: CNS oncology (CNS Oncol) Vol. 10 Issue 2 Pg. CNS72 (06 01 2021) ISSN: 2045-0915 [Electronic] England
• PMID: 34015955 (Publication Type: Journal Article, Review)

Topics

• Brain Neoplasms
• Child
• Humans
• Meningeal Neoplasms (diagnostic imaging, therapy)
• Meningioma (diagnostic imaging, therapy)
• Radiotherapy, Adjuvant